Literature DB >> 9384276

Low apolipoprotein E epsilon4 allele frequency in the population of Catalonia (Spain) determined by PCR-RFLP and Laser fluorescent sequencer.

M Gené1, P Moreno, M Ezquerra, A Prat, E Huguet, R Adroer, R Oliva.   

Abstract

Specific apolipoprotein E alleles have been associated in the last few years with several diseases using appropriate controls. However, these control groups are rarely representative of the general population since they correspond either to aged or healthy control groups (and thus depleted of pathological alleles). For this reason it is difficult at present to compare population allelic frequencies in different countries. In order to provide this essential basic data representative of the general population, in this work we have determined the distribution of apolipoprotein E alleles in 226 individuals from the population of Catalonia (Spain) sampled with the main purpose of paternity testing. The allelic frequencies are: epsilon2 = 0.064, epsilon3 = 0.810 and epsilon4 = 0.126, predicting a lower incidence of Alzheimer disease and possibly also of other pathologies where this allele is a risk factor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9384276     DOI: 10.1023/a:1007389303525

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  25 in total

1.  Apolipoprotein E genotyping by one-stage PCR.

Authors:  P R Wenham; W H Price; G Blandell
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

2.  Disparity between apolipoprotein E phenotypes and genotypes (as determined by polymerase chain reaction and oligonucleotide probes) in patients with non-insulin-dependent diabetes mellitus.

Authors:  C Snowden; R S Houlston; M H Arif; M F Laker; S E Humphries; K G Alberti
Journal:  Clin Chim Acta       Date:  1991-01-31       Impact factor: 3.786

Review 3.  Apolipoprotein E in hyperlipidemia.

Authors:  C C Walden; R A Hegele
Journal:  Ann Intern Med       Date:  1994-06-15       Impact factor: 25.391

4.  Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.

Authors:  J Dallongeville; S Lussier-Cacan; J Davignon
Journal:  J Lipid Res       Date:  1992-04       Impact factor: 5.922

5.  Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world.

Authors:  L U Gerdes; I C Klausen; I Sihm; O Faergeman
Journal:  Genet Epidemiol       Date:  1992       Impact factor: 2.135

Review 6.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

7.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  Epidemiology of cardiovascular disease risk factors in Catalonia (Spain).

Authors:  P Plans; H Pardell; L Salleras
Journal:  Eur J Epidemiol       Date:  1993-07       Impact factor: 8.082

9.  Apolipoprotein E4 allele frequency in Spanish Alzheimer and control cases.

Authors:  R Adroer; P Santacruz; R Blesa; S López-Pousa; C Ascaso; R Oliva
Journal:  Neurosci Lett       Date:  1995-04-21       Impact factor: 3.046

10.  Apolipoprotein E polymorphism in Italy investigated in native plasma by a simple polyacrylamide gel isoelectric focusing technique. Comparison with frequency data of other European populations.

Authors:  R M Corbo; R Scacchi; L Mureddu; G Mulas; G Alfano
Journal:  Ann Hum Genet       Date:  1995-04       Impact factor: 1.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.